170 views | 10 years ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) shares his vision for better IVF clinical outcomes and increased pregnancy rates using next-generation sequencing (NGS). Discover...
147 views | 10 years ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses why he chooses Illumina technology for NIPT, PGS, and PGD. Learn more about how next-generation sequencing (NGS)...
366 views | 10 years ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests...
412 views | 10 years ago
Some people struggle more to lose weight than others. The Fat mass and obesity-associated (FTO) gene is the first gene identified by genome-wide association studies as a strong candidate for obesity-related...
1899 views | 10 years ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing for preimplantation genetic...
247 views | 10 years ago
Highlights from the Illumina User Meeting at AGBT 2015.
1519 views | 10 years ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing http://technology.illumina.com/technology/next-generation-sequencing.html...
116 views | 10 years ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses why he feels Preimplantation Genetic Screening (PGS) should be applied in every IVF treatment. His findings...